Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Malignant Neoplasm of Unknown Primary”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Looking for participantsNCT06589804
What this trial is testing

Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment

Who this might be right for
Metastatic Head and Neck Squamous Cell CarcinomaMetastatic Hypopharyngeal Squamous Cell CarcinomaMetastatic Laryngeal Squamous Cell Carcinoma+18 more
National Cancer Institute (NCI) 158
Early research (Phase 1)Study completedNCT01643499
What this trial is testing

Genotype-guided Dosing of mFOLFIRINOX Chemotherapy in Patients With Previously Untreated Advanced Gastrointestinal Malignancies

Who this might be right for
Acinar Cell Adenocarcinoma of the PancreasAdenocarcinoma of the GallbladderAdenocarcinoma of Unknown Primary+37 more
University of Chicago 79
Early research (Phase 1)Looking for participantsNCT06868433
What this trial is testing

TMV Vaccine Therapy Alone and With Pembrolizumab for the Treatment of Recurrent and/or Metastatic Head and Neck Squamous Cell Cancer

Who this might be right for
Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Metastatic Head and Neck Squamous Cell CarcinomaMetastatic Hypopharyngeal Squamous Cell Carcinoma+20 more
Emory University
Testing effectiveness (Phase 2)Study completedNCT01845337
What this trial is testing

Study to Compare Cardiovascular Side Effects of Teysuno Versus Capecitabine

Who this might be right for
Gastrointestinal CancerCancer of Unknown Primary SitePancreatic Cancer+1 more
University of Edinburgh 59
Testing effectiveness (Phase 2)Study completedNCT00357630
What this trial is testing

Gemcitabine in Treating Patients With Metastatic Cancer of Unknown Primary

Who this might be right for
Carcinoma of Unknown PrimaryPain
Eastern Cooperative Oncology Group 52
Not applicableStudy completedNCT02966509
What this trial is testing

Engagement of Patients With Advanced Cancer

Who this might be right for
End of LifeAdvanced CancerLung Neoplasm+11 more
Stanford University 213
Testing effectiveness (Phase 2)Ended earlyNCT00696943
What this trial is testing

18F ML-10 for Early Detection of Response of Brain Metastases to SRS

Who this might be right for
Metastasis to Brain of Unknown Primary
Aposense Ltd. 1
Large-scale testing (Phase 3)UnknownNCT00022178
What this trial is testing

Combination Chemotherapy in Treating Patients With Metastatic Cancer of an Unknown Site of Origin

Who this might be right for
Carcinoma of Unknown Primary
The Christie NHS Foundation Trust
Testing effectiveness (Phase 2)Study completedNCT03752333
What this trial is testing

Trial of Pembrolizumab in Cancer of Unknown Primary

Who this might be right for
Cancer of Unknown Primary Site
Imperial College London 35
Not applicableLooking for participantsNCT05046444
What this trial is testing

Solving Riddles Through Sequencing

Who this might be right for
LeukemiaHematologic MalignancyRare Diseases+3 more
Munich Leukemia Laboratory 100
Not applicableUnknownNCT06100081
What this trial is testing

Real-time Targeted Fluorescence Endoscopy for Detection of the Primary Cancer Lesion in Patients With a Metastasis of Unknown Primary Tumor in the Head and Neck

Who this might be right for
Unknown Primary TumorsOropharynx Cancer
University Medical Center Groningen 35
Not applicableStudy completedNCT04750109
What this trial is testing

Carcinoma of Unknown Primary (CUP): a Comparison Across Tissue and Liquid Biomarkers

Who this might be right for
Cancer of Unknown Primary Site
The Christie NHS Foundation Trust 117
Not applicableActive Not RecruitingNCT06863870
What this trial is testing

Assessment of Circulating Tumor Cells and microRNAs in Patients With Metastatic Non-cutaneous Melanoma

Who this might be right for
Melanoma Neoplasms
IRCCS Azienda Ospedaliero-Universitaria di Bologna 35
Testing effectiveness (Phase 2)Study completedNCT03422536
What this trial is testing

Ficlatuzumab w/wo Cetuximab in Patients w/Cetuximab-Resistant, Recurrent or Metastatic Head/Neck Squamous Cell Carcinoma

Who this might be right for
Head and Neck Basaloid CarcinomaRecurrent Head and Neck Squamous Cell CarcinomaRecurrent Oropharyngeal Squamous Cell Carcinoma+21 more
University of Arizona 78
Testing effectiveness (Phase 2)Ended earlyNCT00201734
What this trial is testing

Capecitabine, Carboplatin and Weekly Paclitaxel for Patients With Solid Tumors and Adenocarcinoma of Unknown Primary

Who this might be right for
TumorsUnknown Primary TumorsAdenocarcinoma
Ohio State University Comprehensive Cancer Center 57
Not applicableApproved For MarketingNCT04100694
What this trial is testing

Early Access Program Providing HER2/HER3 Bispecific Antibody, MCLA-128, for a Patient With Advanced NRG1-Fusion Positive Solid Tumor

Who this might be right for
NRG1 FusionPancreatic CancerNon Small Cell Lung Cancer+8 more
Merus B.V.
Not applicableLooking for participantsNCT04475640
What this trial is testing

Cancer Genetic Testing in Ethnic Populations

Who this might be right for
Breast CarcinomaCarcinoma of Unknown PrimaryCentral Nervous System Carcinoma+8 more
Mayo Clinic 1,800
Not applicableLooking for participantsNCT06140992
What this trial is testing

PaCIFiC-CUP Classifies Cancer of Unknown Primary

Who this might be right for
Unknown Primary TumorsDNA Methylation
Sun Yat-sen University 120
Testing effectiveness (Phase 2)Active Not RecruitingNCT02721732
What this trial is testing

Pembrolizumab in Treating Patients With Rare Tumors That Cannot Be Removed by Surgery or Are Metastatic

Who this might be right for
Advanced Malignant Solid NeoplasmCarcinoma of Unknown PrimaryMetastatic Adrenal Gland Pheochromocytoma+16 more
M.D. Anderson Cancer Center 157
Very early researchActive Not RecruitingNCT04544098
What this trial is testing

Lutathera in People With Gastroenteropancreatic (GEP), Bronchial or Unknown Primary Neuroendocrine Tumors That Have Spread to the Liver

Who this might be right for
Neuroendocrine TumorsLiver-Dominant Metastatic Pancreatic Neuroendocrine Tumors
Memorial Sloan Kettering Cancer Center 10
Next Page
40